Bone Biologics Corp (NASDAQ: BBLG)
$0.9450
+0.0047 ( +0.53% ) 79.3K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$0.9450
Previous close
$0.9403
Volume
79.3K
Market cap
$2.32M
Day range
$0.9150 - $1.0450
52 week range
$0.8000 - $6.3400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 19, 2024 |
10-q | Quarterly Reports | 57 | Aug 09, 2024 |
ars | Annual reports | 1 | Aug 08, 2024 |
def | Proxies and info statements | 3 | Aug 08, 2024 |
8-k | 8K-related | 19 | Aug 02, 2024 |
8-k | 8K-related | 16 | Jun 20, 2024 |
10-q | Quarterly Reports | 58 | May 14, 2024 |
8-k | 8K-related | 15 | Mar 15, 2024 |
8-k | 8K-related | 23 | Mar 06, 2024 |
8-k | 8K-related | 17 | Mar 01, 2024 |